✦ LIBER ✦

A quantitative investigation of the substantia nigra in Huntington's disease

✍ Scribed by Dr Kiyomitsu Oyanagi; Shigeki Takeda; Hitoshi Takahashi; Eisaku Ohama; Fusahiro Ikuta

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 697 KB
Volume: 26
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410260103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deep brain stimulation in Huntington's d

Deep brain stimulation in Huntington's disease: Globus pallidus externus or substantia nigra pars compacta

✍ Daphna Joel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

High resolution magnetic susceptibility

High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease

✍ Ashley K. Lotfipour; Samuel Wharton; Stefan T. Schwarz; V. Gontu; Andreas Schäfe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract ## Purpose: To determine if tissue magnetic susceptibility is a more direct marker of tissue iron content than other MR markers of iron. This study presents the first quantitative, in vivo measurements of the susceptibility of the substantia nigra in patients with Parkinson's disease.

Transcranial imaging of substantia nigra

Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease

✍ Yu-Wen Huang; Jiann-Shing Jeng; Chung-Fen Tsai; Li-Ling Chen; Ruey-Meei Wu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract Transcranial Doppler imaging (TCDI) has been used as a noninvasive diagnostic tool to differentiate Parkinson's disease (PD) from atypical parkinsonism by detecting hyperechogenicity in the substantia nigra (SN). To our knowledge, no TCDI data are available for Asian populations, and TC

No correlation of substantia nigra echog

No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease

✍ Elmar Lobsien; Simon Schreiner; Michail Plotkin; Andreas Kupsch; Stephan J. Schr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 758 KB

## Abstract ## Background: Substantia nigra hyperechogenicity assessed by transcranial sonography is a typical finding in up to 90% of patients with idiopathic Parkinson's disease, although its value as a surrogate marker for disease progression in Parkinson's disease is controversial. ^123^I‐FP‐C

Five-year follow-up study of hyperechoge

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease

✍ Daniela Berg; Berthold Merz; Karlheinz Reiners; Markus Naumann; Georg Becker 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

## Abstract Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, w

Substantia nigra hyperechogenicity as a

Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease

✍ Katherine J. Schweitzer; Rüdiger Hilker; Uwe Walter; Lothar Burghaus; Daniela Be 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound mar